Elise Salomé-Grosjean

Title: Elise Salomé-Grosjean: Innovator in Neurological Agents

Introduction

Elise Salomé-Grosjean is a prominent inventor based in Herrlisheim, France. She has made significant contributions to the field of neurological agents, holding 2 patents that focus on innovative compounds for treating neurological diseases. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Elise's latest patents include the development of N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids. These compounds are recognized as potent neurological agents. The first aspect of her invention describes a compound, referred to as an 'active agent' or 'active compound,' of Formula I or Ia, or a pharmaceutically acceptable salt or prodrug thereof. Additionally, the compositions and methods of using these compounds for the treatment of neurological diseases are also detailed in her patents.

Career Highlights

Elise is affiliated with the University of North Carolina at Chapel Hill, where she continues her research and development in the field of pharmacology. Her academic background and research focus have positioned her as a key figure in the exploration of new therapeutic agents.

Collaborations

Elise has collaborated with notable colleagues, including Harold L Kohn and Christophe Salomé. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative work.

Conclusion

Elise Salomé-Grosjean is a trailblazer in the development of neurological agents, with a focus on creating effective treatments for neurological diseases. Her contributions to the field are invaluable and continue to inspire future innovations.